Home' Australian Pharmacist : Australian Pharmacist January 2014 Contents Australian Pharmacist January 2014 I © Pharmaceutical Society of Australia Ltd.
72 Australian Pharmacist January 2014 I © Pharmaceutical Society of Australia Ltd.
New edition of Australian
Pharmacy Law and Practice
PSA’s Excellence Awards winner at PAC received copies of the recently
released second edition of Australian Pharmacy Law and Practice written
by Australian Pharmacist legal column writer, Laetitia Hattingh and fellow
authors, John Low and Kim Forrester.
In the forward to
the new edition,
Grant Kardachi, said,
‘ The constantly
evolving nature of
in Australia presents
many challenges for
not the least of which
is staying up to date with the raft of legal,
regulatory and policy developments
that affect our everyday business and
‘ The Pharmaceutical Society of Australia
is pleased to see Chapters 3 and 4
covering ethics and professional conduct,
and practice standards and guidelines.
Pharmacists have a responsibility and
commitment to the profession to be
competent, to practise at the highest
standard and to ensure they serve the
community in Australia in a manner that
optimises the quality use of medicines
and achieves positive health outcomes.
‘Australian Pharmacy Law and Practice
therefore serves a critical need for every
pharmacists in helping to ensure legal
and regulatory compliance, as well as
providing background, history and
discussion of the law so that we can apply
and critically evaluate the information in
the best interests of our practice and our
customers,’ he said.
A feature of the new edition is the wide
range of scenarios presented to help
pharmacists deal with different situations.
Examples of the scenarios include:
Example 1: You become aware that a local
medical practitioner may be involved
in providing prescriptions of injectible
testosterone enanthate to clients for
the sole purpose of enhanced athletic
performance and body building. You also
discover that some of these prescriptions
have been dispensed at your pharmacy.
The product has approved indications
to treat male hypogonadism and male
delayed puberty. Supply for the purpose
of enhanced athletic performance
and body building is not a recognised
indication and would in addition
pose significant long‐term risks to the
patient. In such circumstances it would
not be unreasonable for a regulatory
body to conclude that the action of the
pharmacist was not in accordance with
accepted standards of pharmacy practice.
How would you manage this situation?
Example 2: You need to dispense repeat
prescriptions for a regular elderly patient.
One of the items is for antihypertensive
medication and you have a number
of generic brands on the shelf for this
particular medication that will not attract
What issues should be considered in this
• legislative requirements applicable to
• PBS requirements in terms of generic
• patient factors that should be taken
• practice tools and processes that could
be utilised to promote quality use of
medicines during generic dispensing.
Australian Pharmacy Law and Practice is
available at: www.psa.org.au/shop
Webstercare, was named as Australia’s
sixth Most Innovative Company for 2013
by business magazine BRW as part of its
Annual 50 Most Innovative Companies
survey in December.
BRW specifically highlighted
Webstercare’s MedsPro System utilising
the Virtual Pill Count (VPC) software as
the point of innovation that impressed
The BRW citation said, ‘Success can lead
to its own problems. The huge uptake of
Webster-paks – a sealed blister pack of
medications prepared by a pharmacist
according to a patient’s regime – is
putting increasing pressure on busy
dispensaries that create the packs.
‘ The process of filling Webster‐paks,
which were introduced in the 1980s, has
developed over the years.
‘Webstercare, which makes the packs,
recently took the packing process to
a new level. Packing technicians are
interrupted, often several times, when
preparing a Webster-pak, by running
out of stock, or needing a new script,
for example. These interruptions are
the biggest cause of delay in preparing
Webstercare founder and Managing
Director, Gerard Stevens AM, said,
‘Innovation is at the heart of everything
that we do at Webstercare.
From the initial development of the
Webster-pak systems through to more
recent software innovations such
as MedsPro and the VCP software,
Webstercare is driven by a culture of
solving problems that people have
when managing their medication.
‘I’m also very proud of the recognition
on behalf of the Webstercare staff.
We wouldn’t have a great culture of
innovation without their active input
and belief in what we’re trying to
achieve,’ Mr Stevens said.
Links Archive Australian Pharmacist December 2013 Australian Pharmacist February 2014 Navigation Previous Page Next Page